MLchartDataset catalogue

gp100:154-162 peptide vaccine

Term · Oncology and biomedicine · MLC-T-ONC-014017

A peptide consisting of amino acid residues 154 through 162 of the melanoma-melanocyte antigen gp100. Vaccination with gp100:154-162 peptide may enhance tumor-specific T-cell immunity. gp100 antigen is a self-antigen expressed by melanocytes, pigmented retinal cells, and most melanoma lesions and is recognized via class I and II HLA-restricted mechanisms.

Table 1. Record
IdentifierMLC-T-ONC-014017
FieldOncology and biomedicine
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-014017",
  "term": "gp100:154-162 peptide vaccine",
  "field": "Oncology and biomedicine",
  "definition": "A peptide consisting of amino acid residues 154 through 162 of the melanoma-melanocyte antigen gp100. Vaccination with gp100:154-162 peptide may enhance tumor-specific T-cell immunity. gp100 antigen is a self-antigen expressed by melanocytes, pigmented retinal cells, and most melanoma lesions and is recognized via class I and II HLA-restricted mechanisms.",
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/gp100-154-162-peptide-vaccine/"
}

Record 8,143 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.